Related Experiment Video
Updated: Aug 20, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
Chemoradiotherapy for pancreatic cancer: current status and perspectives
1Department of Radiation Oncology, Graduate School of Medial Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan. n-oya@kaiju.medic.kumamoto-u.ac.jp
Abstract:
The poor prognosis of pancreatic cancer is due to both its metastasis-prone and locally resistant nature. To improve therapeutic outcome, a multimodality approach is necessary. Chemoradiotherapy has been regarded as one of the standard treatment options, particularly for locally advanced pancreatic cancer. A number of clinical studies have been undertaken to establish the use of chemoradiotherapy, with or without surgical resection. This review systematically summarizes the current status, controversies, and prospects of postoperative, definitive, and preoperative chemoradiotherapy for pancreatic cancer.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

